Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Conditions
Myeloproliferative Neoplasms
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama At Birmingham, Birmingham, Alabama, United States
City of Hope-Lennar Foundation Cancer Center, Irvine, California, United States
Usc Norris Comprehensive Cancer Center, Los Angeles, California, United States
UCLA Medical Hematology & Oncology, Los Angeles, California, United States
Yale Cancer Center, New Haven, Connecticut, United States
University of Miami, Miami, Florida, United States
Moffitt Cancer Center, Tampa, Florida, United States
Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
John Hopkins Hospital, Baltimore, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Washington University School of Medicine, St Louis, Missouri, United States
Mount Sinai School of Medicine, New York, New York, United States
Weill Cornell Medicine, New York, New York, United States
University of North Carolina At Chapel Hill, Chapel Hill, North Carolina, United States
Levine Cancer Institute, Charlotte, North Carolina, United States
Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy, Durham, North Carolina, United States
Cleveland Clinic, Cleveland, Ohio, United States
Ohio State University, Columbus, Ohio, United States
Tristar Bmt/Tcto, Nashville, Tennessee, United States
University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Concord General Repatriation Hospital, Concord, New South Wales, Australia
Royal North Shore Hospital, St Leonards, New South Wales, Australia
Icon Cancer Centre, Auchenflower, Queensland, Australia
Epworth Health Care, East Melbourne, Victoria, Australia
Linear Clinical Research, Nedlands, Western Australia, Australia
Centre Hospitalier Universitaire (Chu) de Liege, Liège, Belgium
AZ DELTA, Roeselare, Belgium
McGill University Jewish General Hospital, Montreal, Quebec, Canada
Institut Bergonie, Bordeaux, France
Hospital Saint Louis, Paris, France
Institut Gustave Roussy, Villejuif, France
University Medical Center Rwth Aachen, Aachen, Germany
Charite Universitaetsmedizin Berlin - Campus Charite Mitte, Berlin, Germany
Universitatklinikum Freiburg, Freiburg im Breisgau, Germany
Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii, Mainz, Germany
Aou Policlinico S. Orsola-Malpighi, Bologna, Italy
Fondazione Irccs Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy
A. Gemelli University Hospital, Catholic University of the Sacred Heart, Roma, Italy
Azienda Sanitaria Universitaria Friuli Centrale Asu Fc, Udine, Italy
National Cancer Center Hospital East, Kashiwa Chiba, Japan
Ehime University Hospital, Toon, Ehime, Japan
Hospital Universitari Germans Trias I Pujol, Badalona, Spain
Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Guy'S Hospital - Guy'S & St Thomas' Nhs Foundation Trust, London, United Kingdom
Nottingham University Hospitals, Nottingham, United Kingdom
University of Oxford, Oxford, United Kingdom
Study leads
Incyte Medical Monitor
Study Director
Incyte Corporation